Patients with low bone mass – What is going on?
If the underlying condition remains unrecognised and untreated, the response of secondary osteoporosis to conventional anti-osteoporosis therapy may be incomplete
You will learn:
• The key issues facing the clinician with regard to the patient with secondary osteoporosis
• The risk factors and common causes of secondary osteoporosis, screening, and assessment of fracture risk
• The role of the thyroid gland and diabetes in secondary osteoporosis
• The identification of patients likely to have secondary osteoporosis and the selection of appropriate therapies for their management.
ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report. Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don’t upload these yourself.